BLCO News and Press, Bausch + Lomb Corporation From 05/22/24

2024-05-22 16:31:48 ET Summary Bausch + Lomb, a spin-off from Bausch Health, has shown solid performance with revenues of $4.1bn in 2023 and a narrowing net loss of $(260m). The company's Q1 2024 report shows growth in all segments, including Vision Care, Surgical, and Pharmaceuti...

2024-05-07 09:15:00 ET Summary Bausch Health Companies stock experienced a significant drop after posting its first-quarter results, missing expectations by 13 cents. The company's debt maturity profile raises concerns for investors, with a large amount of debt maturing in 2025 an...

2024-05-06 11:12:29 ET More on Bausch + Lomb Bausch + Lomb Corporation (BLCO) Q1 2024 Earnings Call Transcript Bausch + Lomb Corporation (BLCO) Q4 2023 Earnings Call Transcript Bausch + Lomb Corporation 2023 Q4 - Results - Earnings Call Presentation Bausch + ...

2024-05-02 04:42:01 ET Summary Harrow's long-term bull thesis is stronger than ever, but there may be a credible short-term bear thesis. The short-term bear thesis is the result of the Change Healthcare cyberattack, which has crippled reimbursement and caused huge financial headac...

2024-05-01 13:38:09 ET Bausch + Lomb Corporation (BLCO) Q1 2024 Earnings Conference Call May 01, 2024, 08:00 ET Company Participants George Gadkowski - VP, IR & Business Insights Brent Saunders - Chairman & CEO Sam Eldessouky - EVP & CFO Confere...

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

Revenue of $1.099 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $167 Million Adjusted EBITDA (non-GAAP) 1 of $180 Million Revenue Grew 18% as Reported and 20% on a Constant Currency 1 Basis Compared to the First Quarter of 2023, Driven by Growt...

2024-04-30 12:15:22 ET More on Bausch + Lomb Bausch + Lomb Corporation (BLCO) Q4 2023 Earnings Call Transcript Bausch + Lomb Corporation 2023 Q4 - Results - Earnings Call Presentation Bausch + Lomb reports positive study results for Blink NutriTears Emergent ...

2024-04-30 10:46:05 ET Major earnings expected before the bell on Wednesday include: Ares Capital ( ARCC ) CVS Health ( CVS ) Barrick Gold ( GOLD ) Mastercard ( MA ) Pfizer ( PFE ) Read the full article on Seeking Alpha For further det...

21 Poster Presentations include Evaluations of Consumer, Pharmaceutical, Surgical and Vision Care Products and Pipeline Programs, Including a Novel Dry Eye Nutritional Supplement Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping peopl...